Verquvo
Verquvo is an originator product from Bayer (Schweiz) AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 54.35 to CHF 282.05 depending on the pack; the patient co-payment is 10 per cent plus the deductible.
Core data
- Authorisation holder
- Bayer (Schweiz) AG
- ATC code
- C01DX22
- IT group
- 02.99 Varia
- Active substances
- Vericiguatum
- Preparation type
- Originator product
- On the SL since
- 01/03/2023
- Last price change
- 01/03/2025
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Filmtabl 2.5 mg | Blist 14 Stk | CHF 34.89 | CHF 54.35 | 01/03/2025 | B | 7680680010013 |
| Filmtabl 5 mg | Blist 14 Stk | CHF 34.89 | CHF 54.35 | 01/03/2025 | B | 7680680010037 |
| Filmtabl 5 mg | Blist 98 Stk | CHF 244.23 | CHF 282.05 | 01/03/2025 | B | 7680680010051 |
| Filmtabl 10 mg | Blist 14 Stk | CHF 34.89 | CHF 54.35 | 01/03/2025 | B | 7680680010075 |
| Filmtabl 10 mg | Blist 98 Stk | CHF 244.23 | CHF 282.05 | 01/03/2025 | B | 7680680010099 |
Limitation
This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.
The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.
Zudem kann Verquvo bei erwiesener Intoleranz oder Kontraindikation gegenüber einer Substanzklasse der Basistherapien die bestehende Herzinsuffizienztherapie nach Dekompensation ergänzen.
Vor Initiierung der Behandlung mit Verquvo muss eine ausreichende Stabilisierung nach kürzlich aufgetretener Dekompensation sichergestellt werden, insbesondere bei Patienten mit stark erhöhten NT-proBNP-Spiegeln. Die klinische Stabilisierung schliesst die Behandlung der Volumenüberladung mittels intensivierter (intravenöser) Diuretika-Therapie und die Optimierung der Behandlung mit anderen Standardtherapeutika für Herzinsuffizienz ein.
Die Erstverordnung von Verquvo darf ausschliesslich durch einen Facharzt für Kardiologie erfolgen.
FAQ
Is Verquvo covered by Swiss health insurance?
Yes, but only under conditions. Verquvo is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.
What does Verquvo cost in Switzerland?
The public price is the maximum price set by the FOPH and for Verquvo ranges from CHF 54.35 to CHF 282.05 per pack. The ex-factory price ranges from CHF 34.89 to CHF 244.23. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages